Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F-U Beil

Showing results (41-50 of 44) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 44 results.
Cardiology|January 1, 1990
Lovastatin versus bezafibrate: efficacy, tolerability, and effect on urinary mevalonateF U Beil, A Schrameyer-Wernecke, U Beisiegel, et al.
The American Journal of Medicine|June 6, 1994
Treatment of primary hypercholesterolemia: fluvastatin versus bezafibrateH Greten, F U Beil, J Schneider, et al.
Zeitschrift Fur Kardiologie|December 10, 2003
[Treatment of sudden hearing loss through Fibrinogen/LDL-apheresis. A prospective, randomized multicenter trial]M Suckfüll, D Seidel, J Thiery, et al.
Der Internist|April 29, 2014
[New AHA and ACC guidelines on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk : Statement of the D•A•CH Society for Prevention of Cardiovascular Diseases, the Austrian Atherosclerosis Society and the Working Group on Lipids and Atherosclerosis (AGLA) of the Swiss Society for Cardiology]G Klose, F U Beil, H Dieplinger, et al.
Pageof 5

Showing results (41-50 of 44) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 44 results.
Cardiology|January 1, 1990
Lovastatin versus bezafibrate: efficacy, tolerability, and effect on urinary mevalonateF U Beil, A Schrameyer-Wernecke, U Beisiegel, et al.
The American Journal of Medicine|June 6, 1994
Treatment of primary hypercholesterolemia: fluvastatin versus bezafibrateH Greten, F U Beil, J Schneider, et al.
Zeitschrift Fur Kardiologie|December 10, 2003
[Treatment of sudden hearing loss through Fibrinogen/LDL-apheresis. A prospective, randomized multicenter trial]M Suckfüll, D Seidel, J Thiery, et al.
Der Internist|April 29, 2014
[New AHA and ACC guidelines on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk : Statement of the D•A•CH Society for Prevention of Cardiovascular Diseases, the Austrian Atherosclerosis Society and the Working Group on Lipids and Atherosclerosis (AGLA) of the Swiss Society for Cardiology]G Klose, F U Beil, H Dieplinger, et al.
Pageof 5